Search
for
Sort by
Research 30 of 1000+
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- The quantification of reproductive hormones in the hair of captive adult brown bears and their application as indicators of sex and reproductive state
- Endocrine intervention for transsexuals
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Hypertension and Reproduction
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- Zinc Deficiency in Rhesus and Bonnet Monkeys, Including Effects on Reproduction
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
- Pubertal Development
- Chapter 6. Darwinian Health and Other Contradictions
- Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
- Role of EZH2 in Uterine Gland Development
- Uso da deslorelina na castração química de cães e sua aplicabilidade para o tratamento da alopecia X em Spitz Alemão: relato de caso
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
- Polycystic Ovary Syndrome
- Polycystic ovary syndrome
- The Rotterdam Study: 2018 update on objectives, design and main results
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Reproductive seasonality and maturation throughout the complete life-cycle in the mouflon ram (Ovis musimon)
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Predicting Polycystic Ovary Syndrome among Reproductive-Aged Women in Bangladesh Using Machine Learning Algorithms: Development of a Hospital-Based Predictive Model